India's Biological E looking to make 600 million J&J vaccine shots a year – CEO

FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

NEW DELHI (Reuters) – Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson’s COVID-19 vaccine candidate annually, Mahima Datla, managing director of the privately-held company said on Wednesday.

“We are targeting 600 million doses for J&J,” said Datla. “This will be in addition to our own product for which we are targeting approximately 1 billion doses.”

Source: Read Full Article